CD44 regulates progression and metastasis of several cancers such as breast cancer, prostate cancer, and melanoma [10, 24–27] by interacting with extracellular matrix that promotes cell motility [7] and has an affinity for other ligands, including matrix metalloproteinases (MMPs). This evidence concerns the gene CD44 and melanoma.